Search research articles
Contact Us
Filters
Showing results (41-50 of 59) with videos related to
Page
of 6
Sort By:
International Journal of Molecular Sciences
|
September 3, 2013
PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy
Alain Ruffion, Marian Devonec, Denis Champetier, et al.
BJU International
|
January 19, 2016
Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis
Peter Boyle, Alice Koechlin, Maria Bota, et al.
International Journal of Rheumatic Diseases
|
October 8, 2014
Health-related quality of life and depression in a sample of Latin American adults with rheumatoid arthritis
Hugo Senra, Heather Rogers, Gillian Leibach, et al.
The Journal of Urology
|
February 11, 2003
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study
Christian Pfister, Denis Chautard, Marian Devonec, et al.
International Journal of Molecular Sciences
|
August 1, 2014
Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressiveness
Lucile Tallon, Devillier Luangphakdy, Alain Ruffion, et al.
Brain Injury
|
November 14, 2022
School professionals' knowledge about pediatric traumatic brain injury: an international study
Laiene Olabarrieta-Landa, Daniela Ramos-Usuga, Itziar Benito-Sánchez, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
October 21, 2025
Moderate intermittent hypoxic conditioning to enhance cerebrovascular function in the elderly: a randomized controlled trial
Hugo Randy, Titouan Paul Perrin, Abdallah Ghaith, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
August 23, 2002
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]
Frans Debruyne, Gary Koch, Peter Boyle, et al.
Clinical Biochemistry
|
April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy
Benoit You, Paul Perrin, Gilles Freyer, et al.
European Urology
|
June 21, 2002
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study
Frans Debruyne, Gary Koch, Peter Boyle, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 59) with videos related to
Sort By:
Page
of 6
International Journal of Molecular Sciences
|
September 3, 2013
PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy
Alain Ruffion, Marian Devonec, Denis Champetier, et al.
BJU International
|
January 19, 2016
Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis
Peter Boyle, Alice Koechlin, Maria Bota, et al.
International Journal of Rheumatic Diseases
|
October 8, 2014
Health-related quality of life and depression in a sample of Latin American adults with rheumatoid arthritis
Hugo Senra, Heather Rogers, Gillian Leibach, et al.
The Journal of Urology
|
February 11, 2003
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study
Christian Pfister, Denis Chautard, Marian Devonec, et al.
International Journal of Molecular Sciences
|
August 1, 2014
Comparative evaluation of urinary PCA3 and TMPRSS2: ERG scores and serum PHI in predicting prostate cancer aggressiveness
Lucile Tallon, Devillier Luangphakdy, Alain Ruffion, et al.
Brain Injury
|
November 14, 2022
School professionals' knowledge about pediatric traumatic brain injury: an international study
Laiene Olabarrieta-Landa, Daniela Ramos-Usuga, Itziar Benito-Sánchez, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
October 21, 2025
Moderate intermittent hypoxic conditioning to enhance cerebrovascular function in the elderly: a randomized controlled trial
Hugo Randy, Titouan Paul Perrin, Abdallah Ghaith, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
August 23, 2002
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study]
Frans Debruyne, Gary Koch, Peter Boyle, et al.
Clinical Biochemistry
|
April 29, 2008
Advantages of prostate-specific antigen (PSA) clearance model over simple PSA half-life computation to describe PSA decrease after prostate adenomectomy
Benoit You, Paul Perrin, Gilles Freyer, et al.
European Urology
|
June 21, 2002
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study
Frans Debruyne, Gary Koch, Peter Boyle, et al.
Page
of 6